Rosanto Pharmaceuticals Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$3.96M
Rosanto Pharmaceuticals General Information
Description
Provider of research and development services related to the matter of anti-viral drugs discovery. The company focuses on research and development of anti-viral drugs based on a naturally occurring molecular structure, the cyclopentenone ring of certain prostaglandins.
Contact Information
Website
www.ct-pharma.comCorporate Office
- Magdalen Centre, Robert Robinson Avenue
- Oxford Science Park
- Oxford OX4 4GA
- England, United Kingdom
Corporate Office
- Magdalen Centre, Robert Robinson Avenue
- Oxford Science Park
- Oxford OX4 4GA
- England, United Kingdom
Rosanto Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 24-Apr-2007 | $3.96M | Completed | Generating Revenue | ||
| 3. Merger/Acquisition | 03-Mar-2005 | Completed | Generating Revenue | |||
| 2. Secondary Transaction - Private | 11-Jul-2000 | Completed | Startup | |||
| 1. Early Stage VC | Completed | Startup |
Rosanto Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Rosanto Pharmaceuticals Patents
Rosanto Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-0614848-D0 | Improvements in pharmaceutical compositions | Inactive | 26-Jul-2006 | ||
| GB-0515573-D0 | Improvements in pharmaceutical compositions | Inactive | 28-Jul-2005 | ||
| AU-2003249068-A1 | Bicyclic cylopentanone and cyclopentenone derivatives as potent activators of hsf | Inactive | 06-Aug-2002 | ||
| GB-0218260-D0 | Improvements in pharmaceutically useful compounds | Inactive | 06-Aug-2002 | ||
| AU-2003249069-A1 | Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 | Inactive | 06-Aug-2002 | C07C323/59 |
Rosanto Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Rosanto Pharmaceuticals Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eric Anggard | Corporation | Majority | ||
| HealthCap | Venture Capital | Minority |
Rosanto Pharmaceuticals FAQs
-
When was Rosanto Pharmaceuticals founded?
Rosanto Pharmaceuticals was founded in 1997.
-
Where is Rosanto Pharmaceuticals headquartered?
Rosanto Pharmaceuticals is headquartered in Oxford, United Kingdom.
-
What is the size of Rosanto Pharmaceuticals?
Rosanto Pharmaceuticals has 3 total employees.
-
What industry is Rosanto Pharmaceuticals in?
Rosanto Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Rosanto Pharmaceuticals a private or public company?
Rosanto Pharmaceuticals is a Private company.
-
What is the current valuation of Rosanto Pharmaceuticals?
The current valuation of Rosanto Pharmaceuticals is .
-
What is Rosanto Pharmaceuticals’s current revenue?
The current revenue for Rosanto Pharmaceuticals is .
-
Who are Rosanto Pharmaceuticals’s investors?
Eric Anggard and HealthCap have invested in Rosanto Pharmaceuticals.
-
When was Rosanto Pharmaceuticals acquired?
Rosanto Pharmaceuticals was acquired on 24-Apr-2007.
-
Who acquired Rosanto Pharmaceuticals?
Rosanto Pharmaceuticals was acquired by York Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
